News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,589 Results
Type
Article (41637)
Company Profile (292)
Press Release (688644)
Multimedia
Podcasts (96)
Webinars (20)
Section
Business (205720)
Career Advice (2041)
Deals (35687)
Drug Delivery (128)
Drug Development (81681)
Employer Resources (173)
FDA (16512)
Job Trends (15026)
News (347994)
Policy (32862)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2610)
Accelerated approval (43)
Adcomms (25)
Allergies (164)
Alliances (49929)
ALS (197)
Alzheimer's disease (1762)
Antibody-drug conjugate (ADC) (413)
Approvals (16851)
Artificial intelligence (616)
Autoimmune disease (237)
Automation (51)
Bankruptcy (365)
Best Places to Work (11658)
BIOSECURE Act (21)
Biosimilars (209)
Biotechnology (190)
Bladder cancer (182)
Brain cancer (67)
Breast cancer (702)
Cancer (5511)
Cardiovascular disease (452)
Career advice (1730)
Career pathing (41)
CAR-T (309)
CDC (55)
Celiac Disease (2)
Cell therapy (821)
Cervical cancer (43)
Clinical research (70532)
Collaboration (1990)
Company closure (4)
Compensation (1312)
Complete response letters (74)
COVID-19 (2747)
CRISPR (101)
C-suite (1037)
Cystic fibrosis (151)
Data (7291)
Decentralized trials (3)
Denatured (31)
Depression (156)
Dermatology (70)
Diabetes (555)
Diagnostics (6886)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (308)
Drug pricing (198)
Drug shortages (31)
Duchenne muscular dystrophy (268)
Earnings (91307)
Editorial (62)
Employer branding (21)
Employer resources (152)
Events (119222)
Executive appointments (1057)
FDA (20033)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1666)
Gene editing (219)
Generative AI (54)
Gene therapy (666)
GLP-1 (1032)
Government (4726)
Grass and pollen (6)
Guidances (401)
Healthcare (18979)
HIV (76)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (284)
Immuno-oncology (87)
Indications (164)
Infectious disease (3081)
Inflammatory bowel disease (206)
Inflation Reduction Act (16)
Influenza (133)
Intellectual property (277)
Interviews (316)
IPO (16686)
IRA (52)
Job creations (3681)
Job search strategy (1442)
JPM (58)
Kidney cancer (18)
Labor market (94)
Layoffs (566)
Leadership (35)
Legal (7987)
Liver cancer (98)
Longevity (29)
Lung cancer (737)
Lymphoma (411)
Machine learning (54)
Management (59)
Manufacturing (960)
MASH (179)
Medical device (13889)
Medtech (13971)
Mergers & acquisitions (20181)
Metabolic disorders (1436)
mRNA (183)
Multiple sclerosis (178)
NASH (17)
Neurodegenerative disease (389)
Neuropsychiatric disorders (98)
Neuroscience (3193)
Neurotech (1)
NextGen: Class of 2026 (6558)
Non-profit (4536)
Now hiring (74)
Obesity (678)
Opinion (283)
Ovarian cancer (198)
Pain (240)
Pancreatic cancer (268)
Parkinson's disease (347)
Partnered (35)
Patents (563)
Patient recruitment (622)
Peanut (60)
People (59713)
Pharmaceutical (61)
Pharmacy benefit managers (32)
Phase 1 (22002)
Phase 2 (31061)
Phase 3 (23110)
Pipeline (7491)
Policy (309)
Postmarket research (2567)
Preclinical (9368)
Press Release (64)
Prostate cancer (282)
Psychedelics (50)
Radiopharmaceuticals (312)
Rare diseases (1014)
Real estate (6007)
Recruiting (70)
Regulatory (25173)
Reports (54)
Research institute (2417)
Resumes & cover letters (354)
Rett syndrome (34)
RNA editing (21)
RSV (88)
Schizophrenia (167)
Series A (279)
Series B (207)
Service/supplier (13)
Sickle cell disease (108)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (46)
Startups (3683)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (88)
The Weekly (63)
Vaccines (1074)
Venture capital (101)
Weight loss (435)
Women's health (114)
Worklife (20)
Date
Today (136)
Last 7 days (669)
Last 30 days (2502)
Last 365 days (30363)
2026 (9276)
2025 (30330)
2024 (35325)
2023 (40181)
2022 (51290)
2021 (55834)
2020 (54155)
2019 (46643)
2018 (35124)
2017 (32227)
2016 (31631)
2015 (37709)
2014 (31455)
2013 (26502)
2012 (28772)
2011 (29427)
2010 (27525)
Location
Africa (742)
Alabama (91)
Alaska (7)
Arizona (337)
Arkansas (14)
Asia (39753)
Australia (6522)
California (12560)
Canada (3594)
China (1270)
Colorado (539)
Connecticut (542)
Delaware (377)
Europe (85945)
Florida (1883)
Georgia (403)
Hawaii (3)
Idaho (63)
Illinois (998)
India (86)
Indiana (577)
Iowa (22)
Japan (506)
Kansas (131)
Kentucky (46)
Louisiana (38)
Maine (75)
Maryland (1510)
Massachusetts (8964)
Michigan (350)
Minnesota (687)
Mississippi (6)
Missouri (142)
Montana (33)
Nebraska (29)
Nevada (137)
New Hampshire (84)
New Jersey (3330)
New Mexico (28)
New York (3299)
North Carolina (1586)
North Dakota (8)
Northern California (6232)
Ohio (375)
Oklahoma (23)
Oregon (43)
Pennsylvania (2534)
Puerto Rico (28)
Rhode Island (50)
South America (1115)
South Carolina (82)
South Dakota (2)
Southern California (4941)
Tennessee (202)
Texas (1986)
United States (44430)
Utah (376)
Vermont (1)
Virginia (297)
Washington D.C. (81)
Washington State (1010)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
730,589 Results for "mosaic biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mosaic Therapeutics appoints Dr Vince O’Neill, MD, as Head of R&D
April 1, 2026
·
2 min read
Press Releases
Gordian Bio Releases Preprint Demonstrating Scalable In Vivo Mosaic Screening Platform to Establish Causal Disease Biology
March 4, 2026
·
4 min read
Press Releases
Mosaic Therapeutics to Present Poster Highlighting Preclinical Data for Lead Program MOS101 at the American Association for Cancer Research (AACR) Annual Meeting 2026
March 24, 2026
·
2 min read
Press Releases
AbTherx and Mosaic Biosciences Forge Exclusive Partnership to Provide Milestone and Royalty-Free Access to AbTherx’s Premier Human Antibody Discovery Technology
September 17, 2025
·
4 min read
Press Releases
Mosaic Therapeutics appoints Dr Stephen Shuttleworth as Chief Scientific Officer
November 17, 2025
·
3 min read
Press Releases
Mosaic Therapeutics Appoints Thomas Fuchs as CEO
October 21, 2025
·
2 min read
Press Releases
Forte Biosciences, Inc. Announces 2025 Results and Provides Update
April 1, 2026
·
7 min read
Press Releases
Allosteric Bioscience, Inc. Targets Extending Longevity
March 5, 2026
·
1 min read
Press Releases
Eccogene Announces First Patient Enrolled in MOSAIC Phase 2a Trial Evaluating ECC4703 and ECC0509, Individually and in Combination, for the Treatment of MASH
December 17, 2025
·
2 min read
Biotech Beach
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.
Oncotelic Therapeutics, Inc., announced that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. under which Mosaic will acquire rights to Oncotelic’s clinical-stage necroptosis cancer therapies.
April 29, 2024
·
7 min read
1 of 73,059
Next
